Ron Gibson

511 total citations
10 papers, 358 citations indexed

About

Ron Gibson is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Computer Networks and Communications. According to data from OpenAlex, Ron Gibson has authored 10 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 2 papers in Epidemiology and 1 paper in Computer Networks and Communications. Recurrent topics in Ron Gibson's work include Cystic Fibrosis Research Advances (9 papers), Neonatal Respiratory Health Research (5 papers) and Tracheal and airway disorders (5 papers). Ron Gibson is often cited by papers focused on Cystic Fibrosis Research Advances (9 papers), Neonatal Respiratory Health Research (5 papers) and Tracheal and airway disorders (5 papers). Ron Gibson collaborates with scholars based in United States, Canada and Czechia. Ron Gibson's co-authors include Bonnie W. Ramsey, Margaret Rosenfeld, George Retsch‐Bogart, Pamela L. Zeitlin, Miriam M. Treggiari, Julia Emerson, Jane L. Burns, Jonathan D. Campbell, Moira L. Aitken and Christopher H. Goss and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Pediatrics and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

Ron Gibson

10 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ron Gibson United States	7	309	71	51	43	23	10	358
Luca Romano Italy	10	196 0.6×	109 1.5×	35 0.7×	35 0.8×	28 1.2×	14	330
Andreas Claaß Germany	8	304 1.0×	71 1.0×	54 1.1×	28 0.7×	31 1.3×	13	372
Ulrike Laabs Germany	7	275 0.9×	82 1.2×	9 0.2×	36 0.8×	38 1.7×	7	347
Chandra L. Shrestha United States	13	307 1.0×	92 1.3×	69 1.4×	28 0.7×	16 0.7×	20	405
Erica A. Roesch United States	8	230 0.7×	75 1.1×	30 0.6×	19 0.4×	8 0.3×	17	299
Michael V. Rector United States	6	353 1.1×	93 1.3×	25 0.5×	61 1.4×	2 0.1×	7	436
Yuelin Shen China	8	150 0.5×	26 0.4×	46 0.9×	30 0.7×	6 0.3×	32	234
Katherine L. Tuggle United States	8	251 0.8×	62 0.9×	28 0.5×	31 0.7×	2 0.1×	9	304
Brigitte Wulf Germany	6	311 1.0×	45 0.6×	16 0.3×	10 0.2×	3 0.1×	9	353
Brenda Grogan Ireland	9	211 0.7×	36 0.5×	23 0.5×	33 0.8×	9 0.4×	10	227

Countries citing papers authored by Ron Gibson

Since Specialization

Citations

This map shows the geographic impact of Ron Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Gibson more than expected).

Fields of papers citing papers by Ron Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Gibson. The network helps show where Ron Gibson may publish in the future.

Co-authorship network of co-authors of Ron Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Gibson. A scholar is included among the top collaborators of Ron Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Gibson. Ron Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Cogen, Jonathan D., Don B. Sanders, James E. Slaven, et al.. (2023). Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment. Annals of the American Thoracic Society. 20(9). 1293–1298. 4 indexed citations

2.

Rosenfeld, Margaret, et al.. (2012). Prevalence of cystic fibrosis pathogens in the oropharynx of healthy children and implications for cystic fibrosis care. Journal of Cystic Fibrosis. 11(5). 456–457. 25 indexed citations

3.

Clancy, John, Steven M. Rowe, Zsuzsa Bebők, et al.. (2007). No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations. American Journal of Respiratory Cell and Molecular Biology. 37(1). 57–66. 65 indexed citations

4.

Treggiari, Miriam M., Margaret Rosenfeld, George Retsch‐Bogart, Ron Gibson, & Bonnie W. Ramsey. (2007). Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Pediatric Pulmonology. 42(9). 751–756. 50 indexed citations

5.

Kulich, Michal, Margaret Rosenfeld, Jonathan D. Campbell, et al.. (2005). Disease-specific Reference Equations for Lung Function in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 172(7). 885–891. 50 indexed citations

6.

Deterding, Robin R., George Retsch‐Bogart, Laura Milgram, et al.. (2005). Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y₂ receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatric Pulmonology. 39(4). 339–348. 74 indexed citations

7.

Rosenfeld, Margaret, Ron Gibson, Sharon McNamara, et al.. (2001). Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. The Journal of Pediatrics. 139(4). 572–577. 57 indexed citations

8.

Noone, Peadar G., N. Hamblett, Frank J. Accurso, et al.. (2001). Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi‐center study. Pediatric Pulmonology. 32(2). 122–128. 31 indexed citations

9.

Noone, Peadar G., N. Hamblett, Frank J. Accurso, et al.. (2001). Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi‐center study. Pediatric Pulmonology. 32(2). 122–128. 1 indexed citations

10.

Gibson, Ron, et al.. (1996). Lotus Notes supports distributed teamwork (panel session). 373–373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact